Summary

• Orbit Capital has completed a €107 million second close for Growth Debt Fund II.
• The fund targets post-Series A companies with revenue, growth, and product market fit.
• The raise reinforces venture debt’s role in CEE as scaleups seek growth capital without repeated equity dilution.

Orbit Capital has completed a €107 million second close for its Growth Debt Fund II, adding more specialist debt capacity for Central and Eastern European technology companies trying to finance growth without repeated equity dilution.

The fund targets post-Series A companies with proven product market fit, scalable business models, at least €3 million in annual revenue, and year-on-year growth of more than 30%. Typical investment tickets are expected to range from €3 million to €15 million, supporting expansion, acquisitions, working capital, and capital expenditure.

Its investor base includes the European Investment Fund, Rentea, Česká spořitelna/Erste, Conseq, and PFR Ventures. PFR Ventures’ allocation marks a move by Poland’s state fund of funds into venture debt, while institutional participation from the region points to a broader acceptance of growth debt as part of the scaleup financing mix.

Venture debt is not new to Europe, and the Orbit raise should not be treated as a sudden arrival of the model. It is better understood as evidence that CEE’s financing infrastructure is becoming more specialised. Software and technology enabled companies with recurring revenue often need capital that sits between bank lending and another priced equity round.

The appeal is straightforward. Equity markets have become more selective, valuations are under greater scrutiny, and founders are more cautious about dilution after a volatile funding cycle. Debt can extend runway, fund expansion, or finance acquisitions without immediately resetting ownership. Used well, it gives growing companies more control over timing.

Used badly, it can create pressure at precisely the wrong moment. Venture debt suits companies with revenue quality, growth discipline, and a clear plan for servicing obligations. Orbit’s eligibility criteria show that the fund is not aimed at rescuing early stage companies that have run out of equity options. It is targeting businesses mature enough to carry debt as part of their capital structure.

That distinction matters in CEE. The region has produced credible software, marketplace, fintech, cybersecurity, and health tech companies, but later stage finance remains thinner than in London, Paris, Berlin, or the US. A stronger local venture debt platform can help companies finance international growth without relocating decision making or relying entirely on overseas investors.

Public capital also has a role here. European economies want more scaleups to remain anchored locally, create skilled jobs, and build technology capability in their home markets. Equity alone cannot carry that goal, especially when founders and early investors are trying to manage dilution across longer growth journeys.

The underlying bet is that CEE now has enough companies that can meet the revenue and growth thresholds for debt capital. A €107 million fund will not transform the region by itself, but it can provide useful financing where companies have already shown commercial traction and need more flexible capital than traditional banks are willing to provide.

Orbit has already backed more than 20 companies through its growth capital strategy, according to market reports, and the second fund gives it more room to become a repeat lender for the region’s strongest scaleups. The practical test will be whether borrowers use debt to accelerate durable growth rather than delay harder decisions about costs, product focus, or equity fundraising.

In a more disciplined market, the presence of debt is not automatically a sign of maturity. The stronger signal is whether companies can match the right type of capital to the right stage of growth. Orbit’s fund suggests CEE is building more of that financing range, even as investors continue to demand clearer proof of commercial strength.